期刊文献+

食管鳞癌中RASSF5基因不同转录本的表达及其甲基化状态 被引量:1

Expression and methylation status of dif erent transcripts of RASSF5 in esophageal squamous cell carcinoma
原文传递
导出
摘要 目的 :探讨Ras相关区域家族5(Ras-association domain family 5,RASSF5)基因不同转录本在食管鳞癌(esophageal squamous cell carcinoma,ESCC)中的表达及其甲基化状态。方法 :应用RT-PCR法检测49例食管鳞癌组织及其癌旁正常组织中RASSF5基因不同转录本mRNA的表达及DNA甲基转移酶抑制剂5-氮杂-2’-脱氧胞苷(5-aza-2’-deoxycitydine,5-aza-dC)处理前后食管癌细胞TE1、TE13、T.Tn和Ec109中RASSF5A mRNA的表达;应用甲基化特异性PCR(methylation specii c polymerase chain reaction,MSP)法检测49例食管鳞癌组织及其癌旁正常组织和5-aza-dC处理前后食管癌细胞中RASSF5A甲基化状态,应用免疫组织化学法检测49例食管鳞癌组织及其癌旁正常组织中RASSF5A蛋白的表达。结果 :RASSF5A转录本是在食管鳞状上皮中表达的主要转录本。经5-aza-dC处理后,TE1、TE13、T.Tn和Ec109细胞中RASSF5A mRNA的表达水平均上调(P<0.05);TE1细胞中RASSF5A基因甲基化程度降低,非甲基化程度增加,TE13、T.Tn和Ec109细胞中RASSF5A基因均表现为非甲基化状态。食管鳞癌组织中RASSF5A mRNA的表达水平明显低于癌旁正常组织(P<0.01),其蛋白的阳性表达率(26.5%,13/49)也显著低于癌旁正常组织(75.5%,37/49)(P<0.01)。食管鳞癌组织中RASSF5A基因启动子区的甲基化率(55.1%,27/49)显著高于癌旁正常组织(28.6%,14/49)(P<0.05),并与淋巴结转移和肿瘤组织的分化程度有关(P<0.01)。结论 :食管鳞状上皮组织中RASSF5的主要转录本可能是RASSF5A,RASSF5A基因启动子区异常高甲基化导致的基因沉默可能与食管鳞癌的发生、转移及恶性进程有关。 Objective: To investigate the expressions and methylation status of different transcripts of Ras-association domain family 5 (RASSF5) in esophageal squamous cell carcinoma (ESCC). Methods: The expressions of different transcript mRNAs of RASSF5 in 49 ESCC tissues and the corresponding paracancerous normal tissues and the expression of RASSF5A mRNA in esophageal cancer TE1, TE13, T.Tn and Ec109 cells treated or untreated with 5-aza-2'-deoxycitydine (5-aza-dC) were detected by RT-PCR. The methylation status of RASSF5A in 49 ESCC tissues and the corresponding paracancerous normal tissues and the esophageal cancer cells treated or untreated with 5-aza-dC were detected by methylation-specific polymerase chain reaction (MSP) method. The expression of RASSF5A protein in 49 ESCC tissues and the corresponding paracancerous normal tissues was examined by immunohistochemistry method. Results: RASSF5A was the main transcript that expressed in esophageal squamous epithelium. The expression levels of RASSF5A in TE1, TE13, T.Tn and Ec109 cells after treatment with 5-aza-dC were up-regulated (P 〈 0.05). The methylation level of RASSF5A was decreased and the unmethylation level of RASSF5A was increased in TEl cell, while the unmethylation status of RASSF5A gene was observed in TEl3, T.Tn and Ec109 cells. The expression level of RASSF5A mRNA in ESCC tissues was lower than that in the corresponding paracancerous normal tissues (P 〈 0.01). The positive expression rate of RASSF5A protein in ESCC tissues (26.5%, 13/49) was significantly lower than that in the corresponding paracancerous normal tissues (75.5%, 37/49) (P 〈 0.01). The methylation rate of RASSF5A promoter in ESCC tissues (55.1%, 27/49) was significantly higher than that in the corresponding paracancerous normal tissues (28.6%, 14/49) (P 〈 0.05), and the methylation rate was closely correlated with lymph node metastasis and pathological differentiation (P 〈 0.01). Conclusion= The main transcript of RASSF5 which is expressed in esophageal squamous epithelium may be RASSF5A. The inactivation of RASSF5A caused by aberrant methylation in its promoter region may be closely related to the occurrence, metastasis and progression of ESCC.
出处 《肿瘤》 CAS CSCD 北大核心 2014年第9期831-837,共7页 Tumor
基金 国家自然科学基金资助项目(编号:81101854)
关键词 食管肿瘤 基因表达 甲基化 RASSF5基因 Esophageal neoplasms Gene expression Methylation RASSF5 gene
  • 相关文献

参考文献16

  • 1Feig LA, Buchsbaum RJ. Cell signaling: life ordeath decisions of ras proteins[J]. Curr Biol,2002,12(7):R259-261.
  • 2Agathanggelou A, Cooper WN, Latif F. Role ofthe Ras-association domain family 1 tumorsuppressor gene in human cancers[J]. Cancer Res,2005,65(9):3497-3508.
  • 3Frame S, Balmain A. Integration of positive andnegative growth signals during ras pathwayactivation in vivo[J]. Curr Opin Cenet Dev,2000,10(1):106-113.
  • 4Dammann R, Schagdarsurengin U, Seidel C,et al. The tumor suppressor RASSF1 A in humancarcinogenesis: an update[J].Histoi Histopathol,2005,20(2):645-663.
  • 5Vavvas D, Li X,Avruch J, et al. Identification ofNorel as a potential Ras effector[J].J Biol Chem,1998,273(10):5439-5442.
  • 6Hesson L, Dallol A, Minna JD, et al. NOREl A, ahomologue of RASSF]A tumour suppressor geneis inactivated in human cancers[J]. Oncogene,2003,22(6):947-954.
  • 7Tommasi S, Dammann R, Jin SG, et al. RASSF3and NORE1: identification and cloning of twohuman homologues of the putative tumorsuppressor gene RASSF)[J].Oncogene,2002,21(17):2713-2720.
  • 8张朋,王少康,孙桂菊.食物、营养与食管癌关系的研究进展[J].肿瘤,2011,31(8):768-771. 被引量:9
  • 9Uhlmann K, Rohde K,Zeller C,et al. Distinctmethylation profiles of glioma subtypes[J]. Int J Cancer,2003,106(1):52-59.
  • 10Das PM, Singal R. DNA methylation and cancer[J].J Clin Oncol,2004,22(22):4632-4642.

二级参考文献23

共引文献8

同被引文献15

  • 1Jeltsch A. Beyond Watson and Crick: DNA methylation and molecular enzymology of DNA methyltran sfe rases[J]. Chembiochem, 2002, 3(4):274-293. ~.
  • 2Ksia F, Ziadi S, Dhiab MB, et al. Increased DNA meyltransferase 1 protein expression correlates significantly with int gender Med Sci. estinal histological type and in gastric carcinomas[J]. Adv 2015, 60(1 ):50-57.
  • 3Saa Y, Kan Y, Nakagawa T, et al. Increased protein expression of DNA methylll*ansferase (DNM'F) 1 is significantly correlated with the malignant potential and poor prognosis of human hepatocellular carcinomas[J]. Int J Cancer, 2003, 105(4):527-532.
  • 4Ikeda S, Imura J, Suzuki K. Protein expression, mRNA expression and gene amplification of DNA methyltransferase I in endometrial tumor tissues[I]. Mol C/in Oncol, 2013, 1(3):423-429.
  • 5Gravina GL, Ranieri G, Muzi P, et al. Increased levels of DNA methyltransferases are associated withthe tumorigenic capacity of prostate cancer cells[J]. Oncol Rep, 2013, 29(3):1189-1195.
  • 6He S, Wang F, Yang L, et al. Expression of DNMT1 and DNMT3a are regulated by GLI1 in human pancreatic cancer[J]. P~oS One, 2011,6(11):e27684.
  • 7Zhao SL, Zhu ST, Hao X, et al. Effects of DNA methyltransferase 1 inhibition on esophageal squamous cell carcinoma[J]. Dis Esophagus, 2011, 24(8):601-610.
  • 8Xu XC. Tumor-suppressive activity of retinoic acid receptor-β in cancer[J]. Cancer Lett, 2007, 253(1 ):14-24.
  • 9Herman JG, Baylin SB. Gene silencing in cancer in association with promoter hypermethylation[J].N Engl J Med, 2003, 349(21 ):2042-2054.
  • 10Yoo CB, Jones PA. Epigenetic therapy of cancer: past, present and future[J]. Nat Rev Drug Discov, 2006, 5(1):37-50.

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部